Clinical Research

© Getty Images

Epsilogen completes first-ever IgE antibody clinical trial

By Isabel Cameron

Epsilogen, a leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, has published phase 1 data from the first ever clinical trial of an IgE antibody therapeutic in Nature Communications.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All